LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway

Cancer Cell International
Yang LiQing-Yong Xu

Abstract

Long non-coding RNA H19 (lncRNA H19) has been implicated in tumorigenesis and metastasis of breast cancer through regulating epithelial to mesenchymal transition (EMT); however, the underlying mechanisms remain elusive. LncRNA H19 and TNFAIP8 were identified by qRT-PCR and western blotting. CCK-8 assay, clone formation assay, transwell assay, and flow cytometry assay were performed to determine cell proliferation, migration, invasion and cell cycle of breast cancer respectively. Western blotting and immunohistochemistry (IHC) were utilized to evaluate the protein expression levels of p53, TNFAIP8, and marker proteins of EMT cascades in vivo. Dual luciferase reporter assay and RNA pull down assay were conducted to evaluate the interactions of lncRNA H19, p53 and TNFAIP8. The expression of lncRNA H19 and TNFAIP8 was up-regulated in breast cancer tissues and cell lines, especially in triple-negative breast cancer (TNBC). Functionally, knockdown of lncRNA H19 or TNFAIP8 coused the capacities of cell proliferation, migration, and invasion were suppressed, and cell cycle arrest was induced, as well as that the EMT markers were expressed abnormal. Mechanistically, lncRNA H19 antagonized p53 and increased expression of its target gene ...Continue Reading

References

Jun 30, 2005·The Journal of Biological Chemistry·Nathalie BerteauxEric Adriaenssens
Mar 25, 2006·Cell Death and Differentiation·A J LevineZ Feng
Jan 24, 2007·RNA·Xuezhong Cai, Bryan R Cullen
Mar 17, 2007·Critical Reviews in Eukaryotic Gene Expression·Lauren BrownSam W Lee
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
May 5, 2009·Cell·Karen H Vousden, Carol Prives
Nov 11, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O GluzN Harbeck
May 14, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Stuart J Schnitt
Dec 15, 2010·Molecular Oncology·Aleix Prat, Charles M Perou
Oct 5, 2011·Annals of Surgical Oncology·Yuni Elsa HadisaputriHiroyuki Kuwano
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Jan 3, 2013·International Journal of Cancer. Journal International Du Cancer·Chuanbo ZhangUsha N Kasid
Sep 24, 2013·Molecular Cell·Amanda N KallenYingqun Huang
Apr 8, 2014·Biochimica Et Biophysica Acta·Imad J MatoukAbraham Czerniak
Jul 22, 2014·Cancer·Vandana G AbramsonJennifer A Pietenpol
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 1, 2015·Nature Reviews. Molecular Cell Biology·Flore KruiswijkKaren H Vousden
Jul 23, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Changkun LiuZengjun Wang
Sep 9, 2016·International Journal of Molecular Sciences·Stefanie CerkMartin Pichler
Nov 12, 2016·Cell Death and Differentiation·Julie M LoweMichael B Fessler
Aug 7, 2017·Biochimica Et Biophysica Acta. Molecular Cell Research·Mengxin LvJunxia Chen
Sep 9, 2017·Cell·Edward R Kastenhuber, Scott W Lowe
Apr 26, 2018·Breast Cancer Research and Treatment·Hidetaka ShimaItaru Endo

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
light microscopy
Protein assay
Assay
flow cytometry
pull-down
xenograft
xenografts

Software Mentioned

Quantity One

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.